Brown & Brown, Inc. (BRO) stock analysis
Close on Nov 11, 2026Market cap $23.68BP/E 21.4Yield 0.87%
StockData Score
Prices as of Nov 11, 2026How the score works
Solid15 of 30 checks passed
Brown & Brown passes 15 of the 30 checks behind our score; 11 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 2/6
- Growth
- 4/6
- Past performance
- 3/6
- Financial health
- 2/6
- Dividend
- 4/6
What stands out
Earnings grew over 5 years
Net income grew 17.0% a year on average over the last five fiscal years.
Revenue growing 10%+ a year
Revenue grew 18.2% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 10.1% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 21.9% over the last twelve months, against a 5-year average of 17.0% a year.
What to watch
P/S above the industry
Brown & Brown's price-to-sales of 3.43 is above the Insurance Agents, Brokers, and Service median of 3.43.
Net margin below its 5-year average
Net margin was 17.6% over the last twelve months, against a 5-year average of 19.4%.
Yield below Treasuries
The 0.7% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Brown & Brown yields 0.7%.
Valuation2/6
P/E below its 5-year median
Brown & Brown's P/E of 21.4 is below its own 5-year median of 27.7.
P/E below the industry
Brown & Brown's P/E of 21.4 is below the Insurance Agents, Brokers, and Service median of 30.1.
P/S above the industry
Brown & Brown's price-to-sales of 3.43 is above the Insurance Agents, Brokers, and Service median of 3.43.
P/B against the industry
Needs positive book value.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth4/6
Revenue growing 10%+ a year
Revenue grew 18.2% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 10.1% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 21.9% over the last twelve months, against a 5-year average of 17.0% a year.
Growing faster than the industry
Revenue grew 26.1% over the last twelve months; the Insurance Agents, Brokers, and Service median is 13.8%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
Banks and insurers do not report gross profit.
Past performance3/6
Return on equity
Needs positive equity and five years of results.
Return on assets over 1%
Return on assets was 4.1%; for a bank or insurer, 1% or more is considered good.
Return on equity against the industry
Needs positive equity.
Earnings grew over 5 years
Net income grew 17.0% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 17.6% over the last twelve months, against a 5-year average of 19.4%.
Net margin above the industry
Brown & Brown's net margin of 17.6% is above the Insurance Agents, Brokers, and Service median of 4.9%.
Financial health2/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 20.4% of total debt.
Interest coverage
Interest expense is not reported separately.
Short-term assets cover short-term debts
Current assets are 1.14 times current liabilities.
Bankruptcy risk (Altman Z)
The Altman model does not apply to insurers.
Dividend4/6
Pays a dividend
Brown & Brown paid dividends worth 0.7% of the share price over the last twelve months.
Yield below Treasuries
The 0.7% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Brown & Brown yields 0.7%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Covered by earnings
Dividends take 18.5% of net income.
Covered by free cash flow
Dividends take 15.1% of free cash flow.
Fair value
How we estimate itWe don't publish a fair value for Brown & Brown. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 27.7
- Insurance Agents, Brokers, and Service median 30.1
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $180.59M
- Value traded per 1% price move
- $84.67M
Downside
Medium risk
- Typical loss in a bad month
- 17.3%
- Volatility (annualized)
- 32%
- Sharpe ratio, 1 year
- -0.42
- Beta to the S&P 500 (5Y)
- 0.66
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +22.8% | +18.2% | +17.7% | +13.5% | |
| Net income | +6.1% | +16.2% | +17.0% | +15.8% | |
| EPS, diluted | -8.7% | +10.1% | +13.3% | +14.0% | |
| Free cash flow | +26.6% | +18.6% | +16.6% | +14.3% | |
| Dividend per share | +14.8% | +13.9% | +12.1% | +77.0% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 11.4% | 13.5% | – | |
| Return on assets | 5.0% | 5.8% | 4.4% | |
| Current ratio | 1.20 | 1.26 | 1.04 | |
| Debt to equity | 0.45 | 0.56 | – | |
| Capex to revenue | 1.0% | 2.7% | 1.2% | |
| Diluted shares | 276M | 276M | 313M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Brown & Brown generated $5.32B from operations and spent $1.28B on capital expenditure, dividends and share buybacks. 25% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2023 | 20.5% | 0.30× | 2.83× | 17.1% |
| FY2022 | 18.8% | 0.30× | 2.70× | 15.3% |
| FY2021 | 19.2% | 0.33× | 2.36× | 14.8% |
| FY2020 | 18.4% | 0.32× | 2.33× | 13.5% |
| FY2019 | 16.7% | 0.33× | 2.25× | 12.5% |
| FY2018 | 17.1% | 0.32× | 2.23× | 12.3% |
| FY2017 | 21.2% | 0.34× | 2.23× | 16.2% |
| FY2016 | 14.6% | 0.34× | 2.27× | 11.4% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$1.05B
- Cash generatingOperating cash flow above zero$1.45B
- Return on assets improvedROA up on the prior year6.7% → 6.0%
- Earnings backed by cashOperating cash flow above net income$1.45B vs $1.05B
- Less leverageLong-term debt to assets fell20.4% → 23.0%
- Better liquidityCurrent ratio rose1.10 → 1.04
- No dilutionShare count did not rise284M → 313M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.32 → 0.34
See a number that looks wrong?